SCHEMBL20587766

SCHEMBL20587766

O=C(NN=Cc1cc(OC(F)(F)F)ccc1O)c1ccc(Br)cc1Br

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.58
AR P10275 1/20 0.58
PIK3CG P48736 2/20 0.55
KDM4E B2RXH2 10/20 0.53
KMT2A Q03164 10/20 0.53
MAPT P10636 8/20 0.53
HTT P42858 6/20 0.53
LMNA P02545 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
ALOX12 P18054 2/20 0.53
GPR174 Q9BXC1 1/20 0.51
ADORA2A P29274 1/20 0.51
MEN1 O00255 6/20 0.50
POLB P06746 3/20 0.50
RAB9A P51151 4/20 0.49
NPC1 O15118 2/20 0.49
MITF O75030 2/20 0.49
GAA P10253 2/20 0.49
ASF1A Q9Y294 2/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20587764 1.00 PGR (0.58) PGRARPIK3CGKDM4EKMT2A
SCHEMBL22179491 1.00 PGR (0.58) PGRARPIK3CGKDM4EKMT2A
SCHEMBL22179636 0.88 PGR (0.60) PGRARPIK3CGKDM4EKMT2A
SCHEMBL20587330 0.88 PGR (0.60) PGRARPIK3CGKDM4EKMT2A
SCHEMBL20587328 0.88 PGR (0.60) PGRARPIK3CGKDM4EKMT2A
SCHEMBL20587750 0.86 KMT2A (0.64) PGRARKDM4EKMT2AMAPT
SCHEMBL22179620 0.86 KMT2A (0.64) PGRARKDM4EKMT2AMAPT
SCHEMBL20587751 0.86 KMT2A (0.64) PGRARKDM4EKMT2AMAPT
SCHEMBL22179608 0.85 PIK3CG (0.73) PGRARPIK3CGKDM4EKMT2A
SCHEMBL20587658 0.83 PIK3CG (0.63) PGRARPIK3CGKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12325678-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2025-06-10 US disclosed
US-20240124392-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-04-18 US disclosed
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-01-02 US disclosed
US-20220394973-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-12-15 US disclosed
US-11414378-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-08-16 US disclosed
US-20200207705-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-07-02 US disclosed
EP-3638649-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS The Research Foundation for The State University of New York (US) 2020-04-22 EP disclosed
WO-2018232298-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2018-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220394973-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PGR 4509/4885AR 4255/4885PIK3CG 488/4885
US-12325678-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, SMPD1 PGR 4645/4885AR 4105/4885PIK3CG 383/4885
US-20200207705-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PGR 4509/4885AR 4255/4885PIK3CG 488/4885
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, DPM1 PGR 4509/4885AR 4255/4885PIK3CG 488/4885
US-20240124392-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PGR 4509/4885AR 4255/4885PIK3CG 488/4885
US-11414378-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, LSS PGR 4579/4885AR 3929/4885PIK3CG 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.